Detection of a prostate-specific protein, human glandular kallikrein (hK2), in sera of patients with elevated prostate-specific antigen levels

Urology

Volumn 49, Issue 3, 1997, Pages 487-493

  Charlesworth, M Cristine ^b   Young, Charles Y F ^b   Klee, George G ^b   Saedi, Mohammad S ^b   Mikolajczyk, Stephen D ^b   Finlay, Judith A ^b   Tindall, Donald J ^a  

^a MAYO CLINIC   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

KALLIKREIN; PROSTATE SPECIFIC ANTIGEN; TUMOR MARKER;

AMINO ACID SEQUENCE; AMINO TERMINAL SEQUENCE; ANTIGEN RECOGNITION; ARTICLE; DRUG BLOOD LEVEL; EARLY DIAGNOSIS; EPITHELIUM CELL; HUMAN; HUMAN CELL; MALE; PRIORITY JOURNAL; PROSTATE CANCER; RADIOIMMUNOASSAY;

HUMANS; KALLIKREINS; MALE; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC NEOPLASMS; TISSUE KALLIKREINS;

EID: 0343307126     PISSN: 00904295     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0090-4295(96)00620-6     Document Type: Article

References (23)

1. Parker SL, Tong T, Bolden S, and Wingo PA: Cancer statistics, 1996. CA Cancer J Clin 46: 5-27, 1996.
2. Mettlin C, Jones GW, Averett H, Gusberg SB, and Murphy GP: Defining and updating the American Cancer Society guidelines for the cancer related check up: prostate and endometrial cancer. CA Cancer J Clin 43: 42-46, 1993.
3. Ohori M, Wheeler TM, Dunn JK, Stamey TA, and Scardino PT: The pathological features and prognosis of prostate cancer detectable with current diagnostic tests. J Urol 152: 1714-1720, 1994.
4. Handley MR, and Stuart ME: The use of prostate specific antigen for prostate cancer screening: a managed care perspective. J Urol 152: 1689-1692, 1994.
5. McCormack RT, Rittenhouse HG, Finlay JA, Sokoloff RL, Wang TJ, Wolfert RL, Lilja H, and Oesterling JE: Molecular forms of prostate-specific antigen and the human kallikrein gene family: a new era. Urology 45: 729-744, 1995.
6. Schedlich LJ, Bennetts BH, and Morris BJ: Primary structure of a human glandular kallikrein gene. DNA 6: 429-437, 1987.
7. Chapdelaine P, Paradis G, Tremblay RR, and Dube JY: High level of expression in the prostate of a human glandular kallikrein mRNA related to prostate-specific antigen. FEBS Lett 236: 205-208, 1988.
8. Morris BJ: hGK-1: A kallikrein gene expressed in human prostate. Clin Exp Pharmacol Physiol 16: 345-351, 1989.
9. Henttu P, Lukkarinen O, and Vihko P: Expression of the gene coding for human prostate-specific antigen and related hGK-1 in benign and malignant tumors of the human prostate. Int J Cancer 45: 654-660, 1990.
10. Young CY, Andrews PE, Montgomery BT, and Tindall DJ: Tissue-specific and hormonal regulation of human prostate-specific glandular kallikrein. Biochemistry 31: 818-824, 1992.
11. Drinkwater CC, Evans BA, and Richards RI: Kallikreins, kinins and growth factor biosynthesis. Trends Biochem Sci 13: 169-172, 1988.
12. Grauer LS, Charlesworth MC, Saedi MS, FinlayJA, Liu RS, Kuus-Reichel K, and Tindall DJ: Identification of human glandular kallikrein hK2 from LNCaP cells. J Androl 17: 353-359, 1996.
13. Deperthes D, Chapdelaine P, Tremblay RR, Brunet C, Berton J, Hebert J, Lazure C, and Dube JY: Isolation of prostatic kallikrein hK2, also known as hGK-1, in human seminal plasma. Biochim Biophys Acta 1245: 311-316, 1995.
14. Saedi MS, Cass MMJ, Goel AS, Graur L, Hogen KL, Okaneya T, Griffin BY, Klee GG, Young CYF, and Tindall DJ: Overexpression of a human prostate-specific glandular kallikrein, hK2, in E. coli and generation of antibodies. Mol Cell Endocrinol 109: 237-241, 1995.
15. Sensabaugh GF, and Blake ET: Seminal plasma protein p30: simplified purification and evidence for identity with prostate specific antigen. J Urol 144: 1523-1526, 1990.
16. Berg DT, McClure DB, and Grinnell BW: High level expression of secreted proteins from cells adapted to serum free suspension culture. Biotechniques 14: 972-978, 1993.
17. Laemmli UK: Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227: 680-685, 1970.
18. Towbin H, Staehelin T, and Gordon J: Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications. Proc Natl Acad Sci USA 76: 4350-4354, 1979.
19. Kohler G, and Milstein C: Continuous cultures of fused cells secreting antibody of predefined specificity. Nature 256: 495-497, 1975.
20. 131I-labeled human growth hormone of high specific activity. Biochem J 89: 114-123, 1963.
21. Beyer WH (Ed): Handbook of Tables for Probability and Statistics. Cleveland, CRC, 1966, pp 156-158.
22. Ruckle HC, Klee GG, and Oesterling JE: Prostate-specific antigen: critical issues for the practicing physician. Mayo Clin Proc 69: 59-68, 1994.
23. Finlay JA, Evans C, Day J, Saedi M, Goel A, Cass M, Kumar A, Grauer L, Mikolajczyk S, Hill TM, et al: Development of a dual monoclonal antibody sandwich assay for human glandular kallikrein (hK2) with minimal cross reactivity to prostate specific antigen (PSA) (abstract), in Proceedings of the 1996 International Symposium on the Biology of Prostate Growth, Baltimore, National Institutes of Health, 1996.